RETRACTION : LINC01224 accelerates malignant transformation via MiR ‐193a‐5p/ CDK8 axis in gastric cancer

Retraction: lncRNA HOTAIR promotes gastric cancer proliferation and metastasis via targeting miR‐126 to active CXCR4 and RhoA signaling pathway
Publié: (2024)

An analysis of the relationship of triglyceride glucose index with gastric cancer prognosis: A retrospective study
par: Chao Cai, et autres
Publié: (2024)

Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms
par: Kelly S. Chien, et autres
Publié: (2024)

The effect of self‐designed metabolic equivalent exercises on cancer‐related fatigue in patients with gastric cancer: A randomized controlled trial
par: Xiao Xin, et autres
Publié: (2024)

Facilitators of and barriers to gastric cancer and precursor diagnosis among South Texas residents: Social determinants of health
par: Dorothy Long Parma, et autres
Publié: (2024)

Screening of gastric cancer diagnostic biomarkers in the homologous recombination signaling pathway and assessment of their clinical and radiomic correlations
par: Ahao Wu, et autres
Publié: (2024)

Association of metabolic syndrome and frailty with postoperative complications in older gastric cancer patients: A body composition perspective
par: Xiaoman Jiang, et autres
Publié: (2024)

Impact of immune checkpoint inhibitors on survival outcomes in advanced gastric cancer in Japan: A real‐world analysis
par: Toru Kadono, et autres
Publié: (2024)

An individualized stemness‐related signature to predict prognosis and immunotherapy responses for gastric cancer using single‐cell and bulk tissue transcriptomes
par: Linyong Zheng, et autres
Publié: (2024)

Comparison of SOX and CAPOX in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: A randomized controlled trial
par: Xin Liu, et autres
Publié: (2024)

RETRACTION : ING5 ‐Mediated Antineuroblastoma Effects of Suberoylanilide Hydroxamic Acid
Publié: (2025)

Body composition change indices combined with Prognostic Nutritional Index predicts the clinical outcomes of patients with gastric cancer treated with immune checkpoint inhibitor
par: Guiming Deng, et autres
Publié: (2024)

RSPO3 induced by Helicobacter pylori extracts promotes gastric cancer stem cell properties through the GNG7/β‐catenin signaling pathway
par: Xiwu Rao, et autres
Publié: (2024)

Clinicopathological characteristics of gastric neuroendocrine neoplasms: A comprehensive analysis
par: Mengli Zi, et autres
Publié: (2024)

Artesunate Induces G0 / G1 Phase Arrest in Tumor Cells and Associates With Cyclin‐Dependent Kinase 4 ( CDK4 )
par: Xinyu Chi, et autres
Publié: (2026)

Efficacy and safety of camrelizumab combined with oxaliplatin and S‐1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single‐arm study
par: Wen‐Jin Zhong, et autres
Publié: (2024)

Do corticosteroids affect immunotherapy efficacy in malignancy? – A systematic review
par: Yoni Byron, et autres
Publié: (2024)

The miRNAs 203a/210‐3p/5001‐5p regulate the androgen/androgen receptor/YAP‐induced migration in prostate cancer cells
par: Chieh Huo, et autres
Publié: (2024)

Long non‐coding RNA NEAT1 promotes aerobic glycolysis and progression of cervical cancer through WNT/β‐catenin/PDK1 axis
par: Min Su, et autres
Publié: (2024)

Biomarkers of peripheral blood neutrophil extracellular traps in the diagnosis and progression of malignant tumors
par: Min Wang, et autres
Publié: (2024)

Novel metabolic biomarker for early detection and diagnosis to the patients with gastric cardia adenocarcinoma
par: Meng Xia Wei, et autres
Publié: (2024)

Current treatment and novel insights regarding ROS1‐targeted therapy in malignant tumors
par: Shizhe Li, et autres
Publié: (2024)

Metabolite signature of human malignant thyroid tissue: A systematic review and meta‐analysis
par: S. Adeleh Razavi, et autres
Publié: (2024)

Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma
par: Naita Maren Wirsik, et autres
Publié: (2024)

RETRACTION: Silencing Circular RNA VANGL1 Inhibits Progression of Bladder Cancer by Regulating miR‐1184/IGFBP2 Axis
Publié: (2025)

Association between gut microbiota and malignant cardiac tumors: A two‐sample Mendelian randomization study
par: Yongfei Song, et autres
Publié: (2024)

Arteannuin B Inhibits NSCLC Cells via Regulating miR ‐194‐3p/ CLDN2 Axis
par: Ting‐Sha He, et autres
Publié: (2026)

Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysis
par: Lin‐feng He, et autres
Publié: (2024)

An international multicenter study comparing COVID‐19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab
par: Tali Shafat, et autres
Publié: (2024)

Safety, effectiveness and the optimal duration of preoperative imatinib in locally advanced gastric gastrointestinal stromal tumors: A retrospective cohort study
par: Xiangfei Sun, et autres
Publié: (2024)

MicroRNA Let‐7b‐5p Targets IGF1R to Inhibit the Progression of Hepatocellular Carcinoma Through the AKT/mTOR Pathway
par: Jiaojiao Liang, et autres
Publié: (2025)

TRIM8 promotes ovarian cancer proliferation and migration by targeting VDAC2 for ubiquitination and degradation
par: Fei Wu, et autres
Publié: (2024)

Leaving the parental home, cohabitation, and marriage after a hematologic malignancy in childhood—A register‐based cohort study from the SALiCCS research program
par: Liisa Korhonen, et autres
Publié: (2024)

RETRACTION : Puerarin 6″‐O‐xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K / AKT / mTOR
Publié: (2024)

Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin‐based chemotherapy using short hydration: A randomized phase II trial
par: Eriko Murakami, et autres
Publié: (2024)

RETRACTION: MiR ‐129‐5p Inhibits Glioma Cell Progression In Vitro and In Vivo by Targeting TGIF2
Publié: (2024)